IBRX compared with ABVX: revenue, margins and what each company keeps, and the suppliers and customers both name

IBRXImmunityBio, Inc.

Mkt capRevenueRevenue

ABVXAbivax S.A.

Mkt capRevenueRevenue

Compare

IBRXImmunityBio, Inc.

ABVXAbivax S.A.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IBRX

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.2%▼−2.80%×0.27

May 7 '26±6.7%▼−7.40%×1.10

Q1 FY26±5.5%▲+7.16%×1.31

Feb 23 '26±29.3%▲+12.99%×0.44

ABVX

No earnings history for ABVX.

= impliedIBRX realized, solidABVX realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

IBRXImmunityBio, Inc.

8.29· pre 8.30

Mkt cap$8.8BRevenue$51MQ2 FY26Revenue$140MFY25

ABVXAbivax S.A.

86.58· pre 86.59· delayed

Pre-marketSep 2 '83

Mkt cap$6.0BRevenue—Revenue—

Compare

Pre-marketSep 2 '83

IBRXImmunityBio, Inc.

ABVXAbivax S.A.

8.29pre 8.30

Price

86.58pre 86.59delayed

$8.8B

Mkt cap

$6.0B

Q2 FY26$51M

Revenue

—

FY25$140M

Revenue

—

IBRX8.29vsABVX86.58Pre-marketSep 2 '83